CD49d Is the Strongest Flow Cytometry–Based Predictor of Overall Survival in Chronic Lymphocytic Leukemia | Zendy

Pietro Bulian | Zendy; Tait D. Shanafelt | Zendy; Chris Fegan | Zendy; Antonella Zucchetto | Zendy; Lilla Cro | Zendy; Holger Nückel | Zendy; Luca Baldini | Zendy; Antonina V. Kurtova | Zendy; Alessandra Ferrajoli | Zendy; Jan A. Burger | Zendy; Gianluca Gaïdano | Zendy; Giovanni Del Poeta | Zendy; Chris Pepper | Zendy; Davide Rossi | Zendy; Valter Gattei | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

CD49d Is the Strongest Flow Cytometry–Based Predictor of Overall Survival in Chronic Lymphocytic Leukemia

Author(s) -

Pietro Bulian,

Tait D. Shanafelt,

Chris Fegan,

Antonella Zucchetto,

Lilla Cro,

Holger Nückel,

Luca Baldini,

Antonina V. Kurtova,

Alessandra Ferrajoli,

Jan A. Burger,

Gianluca Gaïdano,

Giovanni Del Poeta,

Chris Pepper,

Davide Rossi,

Valter Gattei

Publication year - 2014

Publication title -

journal of clinical oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 10.482

H-Index - 548

eISSN - 1527-7755

pISSN - 0732-183X

DOI - 10.1200/jco.2013.50.8515

Subject(s) - medicine , chronic lymphocytic leukemia , flow cytometry , overall survival , leukemia , oncology , cancer research , immunology

Although CD49d is an unfavorable prognostic marker in chronic lymphocytic leukemia (CLL), definitive validation evidence is lacking. A worldwide multicenter analysis was performed using published and unpublished CLL series to evaluate the impact of CD49d as an overall (OS) and treatment-free survival (TFS) predictor.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research